The two-day conference and exhibition provides the life science sector, especially chemistry, biology, biotechnology and pharmaceuticals companies, with an array of conferencing, exhibiting and networking opportunities. The events are being staged simultaneously at the Chilford Hall Conference Centre, Cambridge, UK.
The Peptide Conference 2011 features papers from industry and academia and has attracted a strong line-up of prestigious speakers including: Professor Rob Liskamp of Utrecht University, Professor Kevin Burgess of Texas A&M University and Dr Mike Gait of Cambridge University, as well as session chairman Dr Bob Sheppard, combined with senior R&D representatives from Almac Sciences, Mologic, PolyPeptide Group, Peptisyntha, Lonza Braine SA, Chemi Spa, SpheriTech, Bachem Holding, and Novozymes.
Registration is now open for the full conference programme which features papers from industry and academia covering new work and practical application of technologies in the following principal areas:
- Biochemistry of peptides
- Peptides as analytical tools
- Peptides as diagnostics
- Peptide structure and drug discovery
- Therapeutic peptides: development strategies
- Therapeutic peptides: late-stage and commercial developments
- Synthesis and manufacturing technologies
- Peptide drug delivery
Delegate companies at The Peptide Conference 2011 and BioFine Europe 2011 Exhibition already include Bayer HealthCare, Merck & Co and Roche. Exhibitors include: Agilent (Silver Sponsor), Almac Group, American Peptide Company, avakado media, Bachem, Biotage, Celtic Catalysts, IRIS Biotech GmbH, Key Organics, Peptisyntha, PolyPeptide Laboratories, Scientific & Medical Products, sp2 magazine and TCI Europe.
Tom Mulligan, Conference Director, avakado media commented: “We are pleased that the event is drawing in leading opinion leaders and industry brands from within the life science sector. Indeed, the event is specifically targeted at senior R&D scientists, managers and decision makers from pharmaceutical and biotechnology companies looking to develop new peptide analytics, therapeutics and diagnostics and to efficiently and economically manufacture new peptide products”.
Exhibition space at BioFine Europe 2011 is in the process of being booked. Table-tops include power, 2 chairs and space for a pop-up display. Coffees and lunches over the two-day event and attendance at the Networking Reception on Wednesday 20 April are included in the table-top price of £1,250 plus VAT. For more information on exhibiting contact Mark Harrington, Event Director on: Tel: +44 (0)1403 220753, Email: mark@avakado.eu , Web: www.avakado.eu For further information on attending and registering for The Peptide Conference 2011 contact Tom Mulligan, Conference Director on: Tel: +44 (0)1403 220755, Email: tom@avakado.eu, Web: www.avakado.eu
Full venue details: Chilford Hall Vineyard and Conference Centre, Balsham Road, Linton, Cambridgeshire, CB21 4LE, UK. Telephone: +44 (0) 1223 895600 Fax: +44 (0) 1223 895605. Email: events@chilfordhall.co.uk. Website:
www.chilfordhall.co.uk/
Directions: Chilford Hall is about 10 miles (15km) from Cambridge city centre, about 8 miles (12km) from Cambridge railway station and about 12 miles (17km) from Stansted International Airport. For directions to the venue visit www.chilfordhall.co.uk
For media enquiries, please contact:
Tristan Jervis, Associate Director, De Facto Communications, Chime Communication Plc, 330 High Holborn, London WC1V 7QD, T: +44 (0)207 861 3838, E-mail: t.jervis@defacto.com
About avakado media
avakado media is the information provider for the b2b life sciences market. Dynamic and international, avakado media is headquartered just south of London, UK, with regional sales offices in Canada, China and Japan. The markets that avakado serves include: Biotechnology, Fine Chemicals and Pharmaceuticals.
